Click for best price
Intravenous IV Iron Therapy Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Intravenous (IV) Iron Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous (IV) Iron Therapy. This report contains market size and forecasts of Intravenous (IV) Iron Therapy in global, including the following market information:
Global Intravenous (IV) Iron Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Intravenous (IV) Iron Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Ferric Carboxymaltose Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Intravenous (IV) Iron Therapy include Sanofi, Allergan, AMAG Pharmaceuticals, Dalichi Sankyo, Luitpold Pharmaceuticals, Pharmacosmos and Takeda Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Intravenous (IV) Iron Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intravenous (IV) Iron Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Intravenous (IV) Iron Therapy Market Segment Percentages, by Type, 2022 (%)
Ferric Carboxymaltose
Iron Sucrose
Iron Dextran
Others
Global Intravenous (IV) Iron Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Intravenous (IV) Iron Therapy Market Segment Percentages, by Application, 2022 (%)
Nephrology
Gynecology & Obstetrics
Gastroenterology
Oncology
Cardiology
Others
Global Intravenous (IV) Iron Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Intravenous (IV) Iron Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intravenous (IV) Iron Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Intravenous (IV) Iron Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Allergan
AMAG Pharmaceuticals
Dalichi Sankyo
Luitpold Pharmaceuticals
Pharmacosmos
Takeda Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Intravenous (IV) Iron Therapy, market overview.
Chapter 2: Global Intravenous (IV) Iron Therapy market size in revenue.
Chapter 3: Detailed analysis of Intravenous (IV) Iron Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Intravenous (IV) Iron Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Intravenous (IV) Iron Therapy Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Intravenous (IV) Iron Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Intravenous (IV) Iron Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Intravenous (IV) Iron Therapy Overall Market Size
2.1 Global Intravenous (IV) Iron Therapy Market Size: 2022 VS 2032
2.2 Global Intravenous (IV) Iron Therapy Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Intravenous (IV) Iron Therapy Players in Global Market
3.2 Top Global Intravenous (IV) Iron Therapy Companies Ranked by Revenue
3.3 Global Intravenous (IV) Iron Therapy Revenue by Companies
3.4 Top 3 and Top 5 Intravenous (IV) Iron Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Intravenous (IV) Iron Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Intravenous (IV) Iron Therapy Players in Global Market
3.6.1 List of Global Tier 1 Intravenous (IV) Iron Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Intravenous (IV) Iron Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Intravenous (IV) Iron Therapy Market Size Markets, 2022 & 2032
4.1.2 Ferric Carboxymaltose
4.1.3 Iron Sucrose
4.1.4 Iron Dextran
4.1.5 Others
4.2 By Type - Global Intravenous (IV) Iron Therapy Revenue & Forecasts
4.2.1 By Type - Global Intravenous (IV) Iron Therapy Revenue, 2018-2023
4.2.2 By Type - Global Intravenous (IV) Iron Therapy Revenue, 2024-2032
4.2.3 By Type - Global Intravenous (IV) Iron Therapy Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Intravenous (IV) Iron Therapy Market Size, 2022 & 2032
5.1.2 Nephrology
5.1.3 Gynecology & Obstetrics
5.1.4 Gastroenterology
5.1.5 Oncology
5.1.6 Cardiology
5.1.7 Others
5.2 By Application - Global Intravenous (IV) Iron Therapy Revenue & Forecasts
5.2.1 By Application - Global Intravenous (IV) Iron Therapy Revenue, 2018-2023
5.2.2 By Application - Global Intravenous (IV) Iron Therapy Revenue, 2024-2032
5.2.3 By Application - Global Intravenous (IV) Iron Therapy Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Intravenous (IV) Iron Therapy Market Size, 2022 & 2032
6.2 By Region - Global Intravenous (IV) Iron Therapy Revenue & Forecasts
6.2.1 By Region - Global Intravenous (IV) Iron Therapy Revenue, 2018-2023
6.2.2 By Region - Global Intravenous (IV) Iron Therapy Revenue, 2024-2032
6.2.3 By Region - Global Intravenous (IV) Iron Therapy Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Intravenous (IV) Iron Therapy Revenue, 2018-2032
6.3.2 US Intravenous (IV) Iron Therapy Market Size, 2018-2032
6.3.3 Canada Intravenous (IV) Iron Therapy Market Size, 2018-2032
6.3.4 Mexico Intravenous (IV) Iron Therapy Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Intravenous (IV) Iron Therapy Revenue, 2018-2032
6.4.2 Germany Intravenous (IV) Iron Therapy Market Size, 2018-2032
6.4.3 France Intravenous (IV) Iron Therapy Market Size, 2018-2032
6.4.4 U.K. Intravenous (IV) Iron Therapy Market Size, 2018-2032
6.4.5 Italy Intravenous (IV) Iron Therapy Market Size, 2018-2032
6.4.6 Russia Intravenous (IV) Iron Therapy Market Size, 2018-2032
6.4.7 Nordic Countries Intravenous (IV) Iron Therapy Market Size, 2018-2032
6.4.8 Benelux Intravenous (IV) Iron Therapy Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Intravenous (IV) Iron Therapy Revenue, 2018-2032
6.5.2 China Intravenous (IV) Iron Therapy Market Size, 2018-2032
6.5.3 Japan Intravenous (IV) Iron Therapy Market Size, 2018-2032
6.5.4 South Korea Intravenous (IV) Iron Therapy Market Size, 2018-2032
6.5.5 Southeast Asia Intravenous (IV) Iron Therapy Market Size, 2018-2032
6.5.6 India Intravenous (IV) Iron Therapy Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Intravenous (IV) Iron Therapy Revenue, 2018-2032
6.6.2 Brazil Intravenous (IV) Iron Therapy Market Size, 2018-2032
6.6.3 Argentina Intravenous (IV) Iron Therapy Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Intravenous (IV) Iron Therapy Revenue, 2018-2032
6.7.2 Turkey Intravenous (IV) Iron Therapy Market Size, 2018-2032
6.7.3 Israel Intravenous (IV) Iron Therapy Market Size, 2018-2032
6.7.4 Saudi Arabia Intravenous (IV) Iron Therapy Market Size, 2018-2032
6.7.5 UAE Intravenous (IV) Iron Therapy Market Size, 2018-2032
7 Intravenous (IV) Iron Therapy Companies Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Intravenous (IV) Iron Therapy Major Product Offerings
7.1.4 Sanofi Intravenous (IV) Iron Therapy Revenue in Global Market (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Allergan
7.2.1 Allergan Company Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Intravenous (IV) Iron Therapy Major Product Offerings
7.2.4 Allergan Intravenous (IV) Iron Therapy Revenue in Global Market (2018-2023)
7.2.5 Allergan Key News & Latest Developments
7.3 AMAG Pharmaceuticals
7.3.1 AMAG Pharmaceuticals Company Summary
7.3.2 AMAG Pharmaceuticals Business Overview
7.3.3 AMAG Pharmaceuticals Intravenous (IV) Iron Therapy Major Product Offerings
7.3.4 AMAG Pharmaceuticals Intravenous (IV) Iron Therapy Revenue in Global Market (2018-2023)
7.3.5 AMAG Pharmaceuticals Key News & Latest Developments
7.4 Dalichi Sankyo
7.4.1 Dalichi Sankyo Company Summary
7.4.2 Dalichi Sankyo Business Overview
7.4.3 Dalichi Sankyo Intravenous (IV) Iron Therapy Major Product Offerings
7.4.4 Dalichi Sankyo Intravenous (IV) Iron Therapy Revenue in Global Market (2018-2023)
7.4.5 Dalichi Sankyo Key News & Latest Developments
7.5 Luitpold Pharmaceuticals
7.5.1 Luitpold Pharmaceuticals Company Summary
7.5.2 Luitpold Pharmaceuticals Business Overview
7.5.3 Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy Major Product Offerings
7.5.4 Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy Revenue in Global Market (2018-2023)
7.5.5 Luitpold Pharmaceuticals Key News & Latest Developments
7.6 Pharmacosmos
7.6.1 Pharmacosmos Company Summary
7.6.2 Pharmacosmos Business Overview
7.6.3 Pharmacosmos Intravenous (IV) Iron Therapy Major Product Offerings
7.6.4 Pharmacosmos Intravenous (IV) Iron Therapy Revenue in Global Market (2018-2023)
7.6.5 Pharmacosmos Key News & Latest Developments
7.7 Takeda Pharmaceutical
7.7.1 Takeda Pharmaceutical Company Summary
7.7.2 Takeda Pharmaceutical Business Overview
7.7.3 Takeda Pharmaceutical Intravenous (IV) Iron Therapy Major Product Offerings
7.7.4 Takeda Pharmaceutical Intravenous (IV) Iron Therapy Revenue in Global Market (2018-2023)
7.7.5 Takeda Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Intravenous (IV) Iron Therapy Market Opportunities & Trends in Global Market
Table 2. Intravenous (IV) Iron Therapy Market Drivers in Global Market
Table 3. Intravenous (IV) Iron Therapy Market Restraints in Global Market
Table 4. Key Players of Intravenous (IV) Iron Therapy in Global Market
Table 5. Top Intravenous (IV) Iron Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Intravenous (IV) Iron Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Intravenous (IV) Iron Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Intravenous (IV) Iron Therapy Product Type
Table 9. List of Global Tier 1 Intravenous (IV) Iron Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Intravenous (IV) Iron Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Intravenous (IV) Iron Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Intravenous (IV) Iron Therapy Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Intravenous (IV) Iron Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Intravenous (IV) Iron Therapy Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Intravenous (IV) Iron Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Intravenous (IV) Iron Therapy Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2024-2032
Table 30. Sanofi Company Summary
Table 31. Sanofi Intravenous (IV) Iron Therapy Product Offerings
Table 32. Sanofi Intravenous (IV) Iron Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Sanofi Key News & Latest Developments
Table 34. Allergan Company Summary
Table 35. Allergan Intravenous (IV) Iron Therapy Product Offerings
Table 36. Allergan Intravenous (IV) Iron Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Allergan Key News & Latest Developments
Table 38. AMAG Pharmaceuticals Company Summary
Table 39. AMAG Pharmaceuticals Intravenous (IV) Iron Therapy Product Offerings
Table 40. AMAG Pharmaceuticals Intravenous (IV) Iron Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. AMAG Pharmaceuticals Key News & Latest Developments
Table 42. Dalichi Sankyo Company Summary
Table 43. Dalichi Sankyo Intravenous (IV) Iron Therapy Product Offerings
Table 44. Dalichi Sankyo Intravenous (IV) Iron Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Dalichi Sankyo Key News & Latest Developments
Table 46. Luitpold Pharmaceuticals Company Summary
Table 47. Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy Product Offerings
Table 48. Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Luitpold Pharmaceuticals Key News & Latest Developments
Table 50. Pharmacosmos Company Summary
Table 51. Pharmacosmos Intravenous (IV) Iron Therapy Product Offerings
Table 52. Pharmacosmos Intravenous (IV) Iron Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Pharmacosmos Key News & Latest Developments
Table 54. Takeda Pharmaceutical Company Summary
Table 55. Takeda Pharmaceutical Intravenous (IV) Iron Therapy Product Offerings
Table 56. Takeda Pharmaceutical Intravenous (IV) Iron Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Takeda Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Intravenous (IV) Iron Therapy Segment by Type in 2022
Figure 2. Intravenous (IV) Iron Therapy Segment by Application in 2022
Figure 3. Global Intravenous (IV) Iron Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Intravenous (IV) Iron Therapy Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Intravenous (IV) Iron Therapy Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Intravenous (IV) Iron Therapy Revenue in 2022
Figure 8. By Type - Global Intravenous (IV) Iron Therapy Revenue Market Share, 2018-2032
Figure 9. By Application - Global Intravenous (IV) Iron Therapy Revenue Market Share, 2018-2032
Figure 10. By Type - Global Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Intravenous (IV) Iron Therapy Revenue Market Share, 2018-2032
Figure 12. By Application - Global Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Intravenous (IV) Iron Therapy Revenue Market Share, 2018-2032
Figure 14. By Region - Global Intravenous (IV) Iron Therapy Revenue Market Share, 2018-2032
Figure 15. By Country - North America Intravenous (IV) Iron Therapy Revenue Market Share, 2018-2032
Figure 16. US Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Intravenous (IV) Iron Therapy Revenue Market Share, 2018-2032
Figure 20. Germany Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2032
Figure 21. France Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Intravenous (IV) Iron Therapy Revenue Market Share, 2018-2032
Figure 28. China Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2032
Figure 32. India Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Intravenous (IV) Iron Therapy Revenue Market Share, 2018-2032
Figure 34. Brazil Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Intravenous (IV) Iron Therapy Revenue Market Share, 2018-2032
Figure 37. Turkey Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2018-2032
Figure 41. Sanofi Intravenous (IV) Iron Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Allergan Intravenous (IV) Iron Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. AMAG Pharmaceuticals Intravenous (IV) Iron Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Dalichi Sankyo Intravenous (IV) Iron Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pharmacosmos Intravenous (IV) Iron Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Takeda Pharmaceutical Intravenous (IV) Iron Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
